Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05252221 · ClinicalTrials.gov registry record · NA

Alcohol Telemedicine Consultation in Primary Care (ATC)

A NA study of Alcohol Use Disorder (AUD) and Alcohol Problem, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
41,843
Enrollment target
2
Study locations

NCT05252221 is a NA study of Alcohol Use Disorder (AUD) and Alcohol Problem that has completed, run by Kaiser Permanente. The registered enrollment target is 41,843 participants, above the 429-participant average among 30 other Alcohol Use Disorder (AUD) trials with a reported enrollment target (9654% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05252221, a NA study of Alcohol Use Disorder (AUD) and Alcohol Problem, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
41,843 participants
Enrollment target
2
Study locations

Study Summary

This pragmatic, cluster-randomized trial in adult primary care clinics in a healthcare system with a diverse membership will examine the effectiveness of an innovative, multi-faceted intervention, the Addiction Telemedicine Consultant (ATC) service using clinical pharmacists to facilitate alcohol use problems and alcohol use disorder (AUD) pharmacotherapy and specialty addiction treatment entry.

Interventions

  • OTHER ATC Intervention

Study Locations (2)

California

  • Kaiser Permanente - Oakland
  • Kaiser Permanente - San Francisco

Trial Details

FieldValue
Enrollment Target 41,843 participants
Start Date 2021-09-14
Est. Completion 2023-08-31
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT05252221

The ClinicalTrials.gov registry entry for NCT05252221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41,843 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 429-participant average among 30 other Alcohol Use Disorder (AUD) trials with a reported enrollment target (9654% higher). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alcohol Use Disorder (AUD) appearing as the primary indexed condition, and to 1 intervention - of which ATC Intervention is the first listed.

NCT05252221 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05252221 about?

NCT05252221 is a clinical study titled "Alcohol Telemedicine Consultation in Primary Care (ATC)". This pragmatic, cluster-randomized trial in adult primary care clinics in a healthcare system with a diverse membership will examine the effectiveness of an innovative, multi-faceted intervention, the Addiction Telemedicine Consultant (ATC) service using clinical pharmacists to facilitate alcohol us...

What is the current status of trial NCT05252221?

This trial is currently completed. It is a NA study. The enrollment target is 41,843 participants. The study started on 2021-09-14. Estimated completion is 2023-08-31.

What conditions does trial NCT05252221 study?

This clinical trial studies the following conditions: Alcohol Use Disorder (AUD), Alcohol Problem, Pharmacist-Patient Relations.

What interventions are being tested in trial NCT05252221?

The interventions under investigation include: ATC Intervention (OTHER).

Who is sponsoring clinical trial NCT05252221?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05252221 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder (AUD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.